Comparison Tables Core Features What Laboratory Evidence Suggests (Efficacy) Choosing Between Retatrutide and Tirzepatide in One Minute Choose Tirzepatide if your research focuses on: Standardized FDA-approved benchmarks High tolerability and manageable side effects Type 2 Diabetes and insulin resistance Steady, predictable weight loss models Choose Retatrutide if your research focuses on: Maximum weight loss and visceral fat reduction Increasing resting energy expenditure Bypassing adaptive thermogenesis (metabolic slowdown) Investigational triple-agonist pathways Side-by-Side Pros and Cons Pro Tips The Glucagon Trade-off: The addition of glucagon in Retatrutide is a double-edged sword
Stay active and healthy while taking the medication
Healthy Made Simple Achieve healthy weight management with a convenient oral spray
GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study
Waist circumference, systolic blood pressure (BP), triglycerides, and non-high-density lipoprotein cholesterol (non-HDL-C) improved significantly, indicating broad cardiometabolic improvements
Dosing and Administration Recommended Dosages GLP-1 agonists come in various dosage forms and strengths, with specific recommendations for each medication